P53 oncoprotein overexpression in choroidal melanoma

Modern Pathology

Volumn 9, Issue 3, 1996, Pages 267-272

  Janßen, Katharina ^a   Kuntze, Jutta ^a   Busse, Holger ^a   Schmid, Kurt W ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Antigen retrieval; Choroidal melanoma; Immunohistochemistry; Overexpression; P53; Wet autoclave pretreatment

Indexed keywords

ONCOPROTEIN; PROTEIN P53;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; AUTOCLAVE; CHOROID MELANOMA; CLINICAL ARTICLE; EYE CANCER; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; CHOROID NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MELANOMA; MIDDLE AGED; STAINING AND LABELING; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0030008149     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Lane DP, Benchimol S: p53: Oncogene or antioncogen. Genes Dev 4:1, 1990.
2. Levine AJ, Perry ME, Chang A, et al.: The 1993 Walter Hubert Lecture: The role of the p53 tumour suppressor gene in tumorigenesis. Br J Cancer 69:409, 1993.
3. Silvestrini N, Benini E, Daidone MG: p53 as an independent prognostic marker in lymph-node negative breast cancer patients. J Natl Cancer Inst 85:965, 1993.
4. Baker SJ, Preisinger AC, Jessup JM, et al.: p53 gene mutations occur in combinations with 17p allelic deletions as late events in colorectal tumorigenesis. Cancer Res 50:7717, 1990.
5. Reznikoff CA, Kao C, Messing EM, Newton M, Swaminathan S: A molecular genetic model of human bladder carcinogenesis. Semin Cancer Biol 4:143, 1993.
6. Tobal K, Warren W, Cooper CS, McCartney A, Hungerford J, Lightman S: Increased expression and mutation of p53 in choroidal melanoma. Br J Cancer 66:900, 1992.
7. Piffko J, Bankfalvi A, Öfner D, Joos U, Böcker W, Schmid KW: Immunohistochemical detection of p53 protein in archival tissues depends on antigen retrieval. J Pathol 176:69, 1995.
8. Bankfalvi A, Navabi H, Bier B, Böcker W, Jasani B, Schmid KW: Wet autoclave pretreatment for antigen retrieval in diagnostic immunohistochemistry. J Pathol 174:223, 1994.
9. Morgan JM, Navabi H, Schmid KW, Jasani B: Possible role of tissue-bound calcium ions in citrate-mediated high-temperature antigen retrieval. J Pathol 174:301, 1994.
10. Baas IO, Mulder JWR, Johan G, Offerhaus A, Vogelstein B, Hamilton S: An evaluation of six antibodies for immunohis-tochemistry of mutant p53 gene product in archival colorectal neoplasms. J Pathol 172:5, 1994.
11. Öfner D, Maier H, Riedmann B, et al.: Immunohistochemi-cally detectable p53 and mdm-2 oncoprotein expression in colorectal adenocarcinoma: Prognostic significance. J Clin Pathol Mol Pathol 48:M12, 1995.
12. Poremba C, Yandell DW, Huang Q, et al: Frequency and spectrum of 53 mutations in gastric cancer: A molecular genetic and immunohistochemical study. Virchows Arch 426:447, 1995.
13. Lambkin HA, Mothersill CM, Kelehan P: Variations in immunohistochemical detection of p53 protein overexpression in cervical carcinomas with different antibodies and meth-ods of detection. J Pathol 172:13, 1994.
14. Wright PA, Jasani B, Newman GR, Schmid KW, Wynford-Thomas D: p53 immunopositivity is a late event in human thyroid carcinoma development (abstract). J Pathol 169:176, 1993.
15. Schmid KW, Stücker A, Casparu S, et al:, Molecularpathological and immunohistochemical investigations of p53 in human thyroid carcinomas (abstract). Pathol Res Pract 189: 805, 1993.
16. Dockhorn-Dworniczak B, Schröder S, Dantcheva R, et al.: The role of p53 tumor suppressor gene in human thyroid cancer. Exp Clin Endocrinol 101:39, 1993.
17. Bartek J, Bartekova J, Lukas J, Staskova Z, Vojtesek B, Lane DP: Immunohistochemical analysis of the p53 oncoprotein on paraffin sections using a series of novel monoclonal antibodies. J Pathol 169:27, 1993.
18. Esrig D, Spruck CH III, Nichols PW, et al.: p53 nuclear protein accumulation correlates with mutations in the p53 gene, tumor grade, and stage in bladder cancer. Am J Pathol 143:1389, 1993.
19. Wynford-Thomas D: p53 in tumour pathology: Can we trust immunocytochemistry? J Pathol 166:329, 1992.
20. Cesarman E, Inghirami G, Chadburn A, Knowles DM: High levels of p53 protein expression do not correlate with p53 gene mutations in anaplastic large cell lymphoma. Am J Pathol 143:845, 1993.
21. Hall PA, Lane DP: p53 in tumour pathology: Can we trust immunohistochemistry? Revisited! J Pathol 172:1, 1994.
22. MacGeoch C, Barnes DM, Newton JA, et ai: p53 protein detected by immunohistochemical staining is not always mutant. Dis Markers 11:239, 1993.
23. Barnes DM, Hanby AM, Gillet CE, et al.: Abnormal expression of wild-type p53 protein in normal cells of a cancer family patient. Lancet 340:259, 1992.
24. Lane DP, Crawford LV: T antigen is bound to a host protein in SV40-transformed cells. Nature 278:261, 1979.
25. Sarnow P, Ho YS, Williams J, Levine AJ: Adenovirus E1B-58kD tumor antigen and SV40 large tumor antigen are physically associated with the same 54kD cellular protein in transformed cells. Cell 28:387, 1982.
26. Werness BA, Levine AJ, Howley PM: Association of human papillomavirus types 16 and 18 E6 proteins. Science 248:76, 1990.
27. Lehman TA, Bennett WP, Metcalf RA, Welsh JA, Ecker J, Modali RV: p53 mutations, ras mutations and p53-heat shock protein complexes. Cancer Res 51:4090, 1991.
28. Momand J, Zambetti GP, Olson DC, George D, Levine AJ: The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell 69:1237, 1992.
29. Vojtsek B, Lane DP: Regulation of p53 expression in human breast cancer cell lines. J Cell Sci 105:607, 1993.
30. Orazi A, Cattoretti G, Heerema NA, Sozzi G, John K, Neiman RS: Frequent p53 overexpression in therapy related myelodysplastic syndromes and acute myeloid leukemias: An immunohistochemical study of bone marrow biopsies. Mod Pathol 6:521, 1993.